BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 24284780)

  • 1. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
    DiDone L; Oga D; Krysan DJ
    Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
    Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.
    Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K
    Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles.
    Shinde RB; Raut JS; Chauhan NM; Karuppayil SM
    Braz J Infect Dis; 2013; 17(4):395-400. PubMed ID: 23602464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.
    Troskie AM; Rautenbach M; Delattin N; Vosloo JA; Dathe M; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3697-707. PubMed ID: 24752256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
    De Cremer K; Lanckacker E; Cools TL; Bax M; De Brucker K; Cos P; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2015 Jan; 59(1):421-6. PubMed ID: 25367916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
    Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
    Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.
    Uppuluri P; Srinivasan A; Ramasubramanian A; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3591-3. PubMed ID: 21518839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
    J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
    Shuford JA; Rouse MS; Piper KE; Steckelberg JM; Patel R
    J Infect Dis; 2006 Sep; 194(5):710-3. PubMed ID: 16897672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures.
    Vriens K; Cools TL; Harvey PJ; Craik DJ; Spincemaille P; Cassiman D; Braem A; Vleugels J; Nibbering PH; Drijfhout JW; De Coninck B; Cammue BP; Thevissen K
    PLoS One; 2015; 10(8):e0132701. PubMed ID: 26248029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
    Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
    Ko KS; Lee JY; Song JH; Peck KR
    J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
    Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
    J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C; Rodier MH; Daniault G; Imbert C
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.